Cargando…

Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated ROS1/NTRK-Fusion Positive Pediatric High-Grade Glioma

Targeting oncogenic fusion-genes in pediatric high-grade gliomas (pHGG) with entrectinib has emerged as a highly promising therapeutic approach. Despite ongoing clinical studies, to date, no reports on the treatment of cerebrospinal fluid (CSF) disseminated fusion-positive pHGG exist. Moreover, clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayr, Lisa, Guntner, Armin S., Madlener, Sibylle, Schmook, Maria T., Peyrl, Andreas, Azizi, Amedeo A., Dieckmann, Karin, Reisinger, Dominik, Stepien, Natalia M., Schramm, Kathrin, Laemmerer, Anna, Jones, David T. W., Ecker, Jonas, Sahm, Felix, Milde, Till, Pajtler, Kristian W., Blattner-Johnson, Mirjam, Strbac, Miroslav, Dorfer, Christian, Czech, Thomas, Kirchhofer, Dominik, Gabler, Lisa, Berger, Walter, Haberler, Christine, Müllauer, Leonhard, Buchberger, Wolfgang, Slavc, Irene, Lötsch-Gojo, Daniela, Gojo, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766483/
https://www.ncbi.nlm.nih.gov/pubmed/33353026
http://dx.doi.org/10.3390/jpm10040290
_version_ 1783628729359007744
author Mayr, Lisa
Guntner, Armin S.
Madlener, Sibylle
Schmook, Maria T.
Peyrl, Andreas
Azizi, Amedeo A.
Dieckmann, Karin
Reisinger, Dominik
Stepien, Natalia M.
Schramm, Kathrin
Laemmerer, Anna
Jones, David T. W.
Ecker, Jonas
Sahm, Felix
Milde, Till
Pajtler, Kristian W.
Blattner-Johnson, Mirjam
Strbac, Miroslav
Dorfer, Christian
Czech, Thomas
Kirchhofer, Dominik
Gabler, Lisa
Berger, Walter
Haberler, Christine
Müllauer, Leonhard
Buchberger, Wolfgang
Slavc, Irene
Lötsch-Gojo, Daniela
Gojo, Johannes
author_facet Mayr, Lisa
Guntner, Armin S.
Madlener, Sibylle
Schmook, Maria T.
Peyrl, Andreas
Azizi, Amedeo A.
Dieckmann, Karin
Reisinger, Dominik
Stepien, Natalia M.
Schramm, Kathrin
Laemmerer, Anna
Jones, David T. W.
Ecker, Jonas
Sahm, Felix
Milde, Till
Pajtler, Kristian W.
Blattner-Johnson, Mirjam
Strbac, Miroslav
Dorfer, Christian
Czech, Thomas
Kirchhofer, Dominik
Gabler, Lisa
Berger, Walter
Haberler, Christine
Müllauer, Leonhard
Buchberger, Wolfgang
Slavc, Irene
Lötsch-Gojo, Daniela
Gojo, Johannes
author_sort Mayr, Lisa
collection PubMed
description Targeting oncogenic fusion-genes in pediatric high-grade gliomas (pHGG) with entrectinib has emerged as a highly promising therapeutic approach. Despite ongoing clinical studies, to date, no reports on the treatment of cerebrospinal fluid (CSF) disseminated fusion-positive pHGG exist. Moreover, clinically important information of combination with other treatment modalities such as intrathecal therapy, radiotherapy and other targeted agents is missing. We report on our clinical experience of entrectinib therapy in two CSF disseminated ROS1/NTRK-fusion-positive pHGG cases. Combination of entrectinib with radiotherapy or intrathecal chemotherapy appears to be safe and has the potential to act synergistically with entrectinib treatment. In addition, we demonstrate CSF penetrance of entrectinib for the first time in patient samples suggesting target engagement even upon CSF dissemination. Moreover, in vitro analyses of two novel cell models derived from one case with NTRK-fusion revealed that combination therapy with either a MEK (trametinib) or a CDK4/6 (abemaciclib) inhibitor synergistically enhances entrectinib anticancer effects. In summary, our comprehensive study, including clinical experience, CSF penetrance and in vitro data on entrectinib therapy of NTRK/ROS1-fusion-positive pHGG, provides essential clinical and preclinical insights into the multimodal treatment of these highly aggressive tumors. Our data suggest that combined inhibition of NTRK/ROS1 and other therapeutic vulnerabilities enhances the antitumor effect, which should be followed-up in further preclinical and clinical studies.
format Online
Article
Text
id pubmed-7766483
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-77664832020-12-28 Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated ROS1/NTRK-Fusion Positive Pediatric High-Grade Glioma Mayr, Lisa Guntner, Armin S. Madlener, Sibylle Schmook, Maria T. Peyrl, Andreas Azizi, Amedeo A. Dieckmann, Karin Reisinger, Dominik Stepien, Natalia M. Schramm, Kathrin Laemmerer, Anna Jones, David T. W. Ecker, Jonas Sahm, Felix Milde, Till Pajtler, Kristian W. Blattner-Johnson, Mirjam Strbac, Miroslav Dorfer, Christian Czech, Thomas Kirchhofer, Dominik Gabler, Lisa Berger, Walter Haberler, Christine Müllauer, Leonhard Buchberger, Wolfgang Slavc, Irene Lötsch-Gojo, Daniela Gojo, Johannes J Pers Med Article Targeting oncogenic fusion-genes in pediatric high-grade gliomas (pHGG) with entrectinib has emerged as a highly promising therapeutic approach. Despite ongoing clinical studies, to date, no reports on the treatment of cerebrospinal fluid (CSF) disseminated fusion-positive pHGG exist. Moreover, clinically important information of combination with other treatment modalities such as intrathecal therapy, radiotherapy and other targeted agents is missing. We report on our clinical experience of entrectinib therapy in two CSF disseminated ROS1/NTRK-fusion-positive pHGG cases. Combination of entrectinib with radiotherapy or intrathecal chemotherapy appears to be safe and has the potential to act synergistically with entrectinib treatment. In addition, we demonstrate CSF penetrance of entrectinib for the first time in patient samples suggesting target engagement even upon CSF dissemination. Moreover, in vitro analyses of two novel cell models derived from one case with NTRK-fusion revealed that combination therapy with either a MEK (trametinib) or a CDK4/6 (abemaciclib) inhibitor synergistically enhances entrectinib anticancer effects. In summary, our comprehensive study, including clinical experience, CSF penetrance and in vitro data on entrectinib therapy of NTRK/ROS1-fusion-positive pHGG, provides essential clinical and preclinical insights into the multimodal treatment of these highly aggressive tumors. Our data suggest that combined inhibition of NTRK/ROS1 and other therapeutic vulnerabilities enhances the antitumor effect, which should be followed-up in further preclinical and clinical studies. MDPI 2020-12-18 /pmc/articles/PMC7766483/ /pubmed/33353026 http://dx.doi.org/10.3390/jpm10040290 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mayr, Lisa
Guntner, Armin S.
Madlener, Sibylle
Schmook, Maria T.
Peyrl, Andreas
Azizi, Amedeo A.
Dieckmann, Karin
Reisinger, Dominik
Stepien, Natalia M.
Schramm, Kathrin
Laemmerer, Anna
Jones, David T. W.
Ecker, Jonas
Sahm, Felix
Milde, Till
Pajtler, Kristian W.
Blattner-Johnson, Mirjam
Strbac, Miroslav
Dorfer, Christian
Czech, Thomas
Kirchhofer, Dominik
Gabler, Lisa
Berger, Walter
Haberler, Christine
Müllauer, Leonhard
Buchberger, Wolfgang
Slavc, Irene
Lötsch-Gojo, Daniela
Gojo, Johannes
Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated ROS1/NTRK-Fusion Positive Pediatric High-Grade Glioma
title Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated ROS1/NTRK-Fusion Positive Pediatric High-Grade Glioma
title_full Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated ROS1/NTRK-Fusion Positive Pediatric High-Grade Glioma
title_fullStr Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated ROS1/NTRK-Fusion Positive Pediatric High-Grade Glioma
title_full_unstemmed Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated ROS1/NTRK-Fusion Positive Pediatric High-Grade Glioma
title_short Cerebrospinal Fluid Penetration and Combination Therapy of Entrectinib for Disseminated ROS1/NTRK-Fusion Positive Pediatric High-Grade Glioma
title_sort cerebrospinal fluid penetration and combination therapy of entrectinib for disseminated ros1/ntrk-fusion positive pediatric high-grade glioma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766483/
https://www.ncbi.nlm.nih.gov/pubmed/33353026
http://dx.doi.org/10.3390/jpm10040290
work_keys_str_mv AT mayrlisa cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma
AT guntnerarmins cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma
AT madlenersibylle cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma
AT schmookmariat cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma
AT peyrlandreas cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma
AT aziziamedeoa cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma
AT dieckmannkarin cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma
AT reisingerdominik cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma
AT stepiennataliam cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma
AT schrammkathrin cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma
AT laemmereranna cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma
AT jonesdavidtw cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma
AT eckerjonas cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma
AT sahmfelix cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma
AT mildetill cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma
AT pajtlerkristianw cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma
AT blattnerjohnsonmirjam cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma
AT strbacmiroslav cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma
AT dorferchristian cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma
AT czechthomas cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma
AT kirchhoferdominik cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma
AT gablerlisa cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma
AT bergerwalter cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma
AT haberlerchristine cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma
AT mullauerleonhard cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma
AT buchbergerwolfgang cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma
AT slavcirene cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma
AT lotschgojodaniela cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma
AT gojojohannes cerebrospinalfluidpenetrationandcombinationtherapyofentrectinibfordisseminatedros1ntrkfusionpositivepediatrichighgradeglioma